On the other hand, CTNNB1 (1), GNAS (2), NTRK1 (1), and ZNF148 (4) gene mutations occur exclusively in benign tumors with low mutation frequency, indicating they lack the capability to initiate malignant progression on their own. Here, CTNNB1 is linked to benign neoplasm.